BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1866369)

  • 1. Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated diabetic rats.
    Sato H; Terasaki T; Okumura K; Tsuji A
    Pharm Res; 1991 May; 8(5):563-9. PubMed ID: 1866369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats.
    Philippe J; Halban PA; Gjinovci A; Duckworth WC; Estreicher J; Renold AE
    J Clin Invest; 1981 Mar; 67(3):673-80. PubMed ID: 6451633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased affinity of insulin receptor on hepatocytes from streptozotocin-induced diabetic rats.
    Okamoto M; Kuzuya H; Imura H
    Endocrinol Jpn; 1984 Jun; 31(3):235-43. PubMed ID: 6389099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
    Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
    Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo insulin responsiveness for glucose uptake and production at eu- and hyperglycemic levels in normal and diabetic rats.
    Koopmans SJ; Maassen JA; Radder JK; Frölich M; Krans HM
    Biochim Biophys Acta; 1992 Jan; 1115(3):230-8. PubMed ID: 1739737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of anticholinergic drugs and brain muscarinic receptor alterations in streptozotocin diabetic rats.
    Nakashima E; Ishizaki J; Takeda M; Matsushita R; Yokogawa K; Ichimura F
    Biopharm Drug Dispos; 1993 Nov; 14(8):673-84. PubMed ID: 8305628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms of up-regulation of the hepatic insulin receptor in hypoinsulinemic diabetes mellitus.
    Salhanick AI; West H; Amatruda JM
    J Biol Chem; 1985 Dec; 260(30):16232-6. PubMed ID: 3905811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postreceptor defect in insulin action in streptozotocin-induced diabetic rats.
    Nishimura H; Kuzuya H; Okamoto M; Yamada K; Kosaki A; Kakehi T; Inoue G; Kono S; Imura H
    Am J Physiol; 1989 May; 256(5 Pt 1):E624-30. PubMed ID: 2655470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.
    Rossetti L; DeFronzo RA; Gherzi R; Stein P; Andraghetti G; Falzetti G; Shulman GI; Klein-Robbenhaar E; Cordera R
    Metabolism; 1990 Apr; 39(4):425-35. PubMed ID: 2157941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
    Blondel O; Simon J; Chevalier B; Portha B
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
    Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A
    Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dephosphorylation of the insulin receptor partially restores the decreased autophosphorylation in streptozotocin induced diabetic rats.
    Iwama N; Watarai T; Kajimoto Y; Yamasaki Y; Yokoyama T; Kawamori R; Kamada T
    Diabetes Res; 1991 May; 17(1):25-32. PubMed ID: 1816977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of 125I-labelled insulin-binding sites in peripheral tissues of the normal and diabetic rat: an autoradiographic study.
    Thompson CS; Sykes RM; Muddle J; Dashwood MR
    J Endocrinol; 1991 Jan; 128(1):85-9. PubMed ID: 1999679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptors on erythrocytes and hepatocytes from streptozotocin induced diabetic rats.
    Okamoto M; Kuzuya H; Kuo P; Imura H
    Endocrinol Jpn; 1982 Oct; 29(5):623-30. PubMed ID: 6221923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
    Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
    Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alloxan diabetes and phenformin on insulin binding with liver plasma membrane receptors.
    Chaujar M; Chaudhuri BN; Yadav HS; Chauhan UP
    Jpn J Exp Med; 1984 Oct; 54(5):189-93. PubMed ID: 6398835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of streptozotocin at the insulin pre-receptor, receptor and post-receptor level in adipocytes of rats].
    Mayor P; Calle C
    Rev Esp Fisiol; 1987 Dec; 43(4):445-53. PubMed ID: 2966423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased insulin action in cultured hepatocytes from rats with diabetes induced by neonatal streptozotocin.
    Melin B; Caron M; Cherqui G; Blivet MJ; Bailbe D; Picard J; Capeau J; Portha B
    Endocrinology; 1991 Apr; 128(4):1693-701. PubMed ID: 1848501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of up-regulation of the liver insulin receptor in chronically hypoinsulinemic rats: assessment of receptor endocytosis.
    Lopez S; Burlet H; Desbuquois B
    Mol Cell Endocrinol; 1991 Dec; 82(2-3):159-64. PubMed ID: 1838992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.